Diaceutics Aktie - DXRX

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

135,00

Gebot

134,00

Fragen

136,00

Volumen

70.552

134,00 Tagesbereich 135,00

93,50 52-Wochen-Bereich 148,00

Marktkapitalisierung

114,453M

Handelsende

133,00

Handelsbeginn

134,00

Letzte Trade

5000

134

(O)

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

103.625

Ausgegebene Aktien

84.780.127

Dividendenrendite

Kurs-Gewinn-Verhältnis

-65,53

Gewinn pro Aktie (EPS)

-0,02

Erlöse

23,7M

Nettogewinn

-1,75M

Sektor

Testing Laboratories

Branche

Testing Laboratories

Website

www.diaceutics.com

Hauptsitz

Belfast, Irl

Gegründet

Diaceutics Plc is listed in the Testing Laboratories sector of the Londoner Börse with ticker DXRX. The last closing price for Diaceutics was 133,00p. Over the last year, Diaceutics shares have traded in a share price range of 93,50p to 148,00p.

Diaceutics currently has 84.780.127 shares in issue. The market capitalisation of Diaceutics is £112,76 million. Diaceutics has a price to earnings ratio (PE ratio) of -65.53.

Diaceutics PLC Purchase of Shares and PDMR Shareholding

Diaceutics PLC 31 January 2025 Diaceutics PLC Purchase of Shares and PDMR Shareholding New York, Belfast and London, 31 January 2025 - Diaceutics PLC (AIM: DXRX), a leading...

Diaceutics PLC PDMR Shareholding/Share Incentive Plan

Diaceutics PLC 30 January 2025 Diaceutics PLC PDMR Shareholding/Share Incentive Plan New York, Belfast and London, 30 January 2025 - Diaceutics PLC (AIM: DXRX), a leading technology...

EARNINGS AND TRADING: S-Ventures loss narrows; charge knocks Nuformix

The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and Wednesd ...

Diaceutics PLC FY 2024 Trading Update - Strong Revenue Growth

Diaceutics PLC 28 January 2025 Diaceutics FY 2024 Trading Update Revenue grows 39% on a constant currency basis to £32.2 million in FY 2024 FY 2024 Adjusted EBITDA* expected to be...

IN BRIEF: Diaceutics opens new US headquarters in New Jersey

Belfast-based provider of diagnostic commercialisation services to pharmaceutical and biotechnology companies - Opens ...

Diaceutics PLC Diaceutics Opens US Headquarters

Diaceutics PLC 14 January 2025 Diaceutics Opens US Headquarters New US office in New Jersey will facilitate growth of local sales & marketing teams close to Diaceutics' pharma...

Diaceutics launches new engagement service with 12-month contract win

Diaceutics PLC on Wednesday said it has launched its new pathology engagement liaisons service, and secured a new 12- ...

Diaceutics PLC New Service Launched & First Contract Signed

Diaceutics PLC 08 January 2025 Diaceutics Launches New Service and Signs First Contract for up to $1.8m New Pathology Engagement Liaisons service (PEL) launched PEL will augment the...

Diaceutics PLC PDMR Dealings & Total Voting Rights

Diaceutics PLC 03 January 2025 Diaceutics PLC PDMR Shareholding/Share Incentive Plan and Total Voting Rights Belfast and London, 3 January 2025 - Diaceutics PLC (AIM: DXRX), a leading...

Diaceutics PLC Holding(s) in Company

Diaceutics PLC 19 December 2024 Notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i...

Diaceutics PLC Purchase of Shares and PDMR Shareholding

Diaceutics PLC 31 January 2025 Diaceutics PLC Purchase of Shares and PDMR Shareholding New York, Belfast and London, 31 January 2025 - Diaceutics PLC (AIM: DXRX), a leading...

Diaceutics PLC PDMR Shareholding/Share Incentive Plan

Diaceutics PLC 30 January 2025 Diaceutics PLC PDMR Shareholding/Share Incentive Plan New York, Belfast and London, 30 January 2025 - Diaceutics PLC (AIM: DXRX), a leading technology...

EARNINGS AND TRADING: S-Ventures loss narrows; charge knocks Nuformix

The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and Wednesd ...

Diaceutics PLC FY 2024 Trading Update - Strong Revenue Growth

Diaceutics PLC 28 January 2025 Diaceutics FY 2024 Trading Update Revenue grows 39% on a constant currency basis to £32.2 million in FY 2024 FY 2024 Adjusted EBITDA* expected to be...

IN BRIEF: Diaceutics opens new US headquarters in New Jersey

Belfast-based provider of diagnostic commercialisation services to pharmaceutical and biotechnology companies - Opens ...

Diaceutics PLC Diaceutics Opens US Headquarters

Diaceutics PLC 14 January 2025 Diaceutics Opens US Headquarters New US office in New Jersey will facilitate growth of local sales & marketing teams close to Diaceutics' pharma...

Diaceutics launches new engagement service with 12-month contract win

Diaceutics PLC on Wednesday said it has launched its new pathology engagement liaisons service, and secured a new 12- ...

Diaceutics PLC New Service Launched & First Contract Signed

Diaceutics PLC 08 January 2025 Diaceutics Launches New Service and Signs First Contract for up to $1.8m New Pathology Engagement Liaisons service (PEL) launched PEL will augment the...

Diaceutics PLC PDMR Dealings & Total Voting Rights

Diaceutics PLC 03 January 2025 Diaceutics PLC PDMR Shareholding/Share Incentive Plan and Total Voting Rights Belfast and London, 3 January 2025 - Diaceutics PLC (AIM: DXRX), a leading...

Diaceutics PLC Holding(s) in Company

Diaceutics PLC 19 December 2024 Notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i...

Diaceutics PLC Holding(s) in Company

Diaceutics PLC 17 December 2024 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BJQTGV64 Issuer Name DIACEUTICS PLC UK or Non-UK Issuer UK 2. Reason for...

Diaceutics PLC Diaceutics Wins New $5.1m Contract

Diaceutics PLC 17 December 2024 Diaceutics Wins New $5.1m Contract Second largest contract win in Diaceutics' history A global pharma customer has selected the DXRX platform to deliver...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	-2	-1.4598540146	137	137	133	30506	134.96496381	DE
4	-10.5	-7.21649484536	145.5	148	133	106511	143.32739279	DE
12	15	12.5	120	148	116	103625	132.75318385	DE
26	11	8.87096774194	124	148	116	96769	131.49779216	DE
52	36.5	37.0558375635	98.5	148	93.5	99384	123.72702705	DE
156	22	19.4690265487	113	148	74.5	60556	110.82243345	DE
260	-32.5	-19.4029850746	167.5	191	74.5	61795	116.86449874	DE

DXRX - Frequently Asked Questions (FAQ)

What is the current Diaceutics share price?

The current share price of Diaceutics is 135,00p

How many Diaceutics shares are in issue?

Diaceutics has 84.780.127 shares in issue

What is the market cap of Diaceutics?

The market capitalisation of Diaceutics is GBP 112,76M

What is the 1 year trading range for Diaceutics share price?

Diaceutics has traded in the range of 93,50p to 148,00p during the past year

What is the PE ratio of Diaceutics?

The price to earnings ratio of Diaceutics is -65,53

What is the cash to sales ratio of Diaceutics?

The cash to sales ratio of Diaceutics is 4,83

What is the reporting currency for Diaceutics?

Diaceutics reports financial results in GBP

What is the latest annual turnover for Diaceutics?

The latest annual turnover of Diaceutics is GBP 23,7M

What is the latest annual profit for Diaceutics?

The latest annual profit of Diaceutics is GBP -1,75M

What is the registered address of Diaceutics?

The registered address for Diaceutics is FIRST FLOOR, BUILDING TWO, DATAWORKS AT KINGS HALL HEALTH, AND WELLBEING PARK, BELFAST, BT9 6GW

What is the Diaceutics website address?

The website address for Diaceutics is www.diaceutics.com

Which industry sector does Diaceutics operate in?

Diaceutics operates in the TESTING LABORATORIES sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
ASTAscent Resources Plc	1,90p (100,00%)	591,55k
NTQEnteq Technologies Plc	2,85p (58,33%)	17,97M
THRUThruvision Group Plc	3,25p (30,00%)	307,66k
IMMImmupharma Plc	4,98p (27,69%)	14,75M
GEXGeorgina Energy Plc	6,375p (24,39%)	5,16M
BELLBelluscura Plc	1,875p (-71,15%)	13,68M
APQApq Global Limited	2,00p (-69,23%)	60,87k
IOMIomart Group Plc	45,40p (-23,57%)	1,76M
SYMESupply@me Capital Plc	0,002p (-20,00%)	736,23M
PRMProteome Sciences Plc	3,50p (-17,45%)	50,06k
SYMESupply@me Capital Plc	0,002p (-20,00%)	736,23M
ORCPOracle Power Plc	0,017p (-14,14%)	523,64M
CPAICapai Plc	0,0475p (7,95%)	355,25M
NTVONativo Resources Plc	0,0017p (0,00%)	347,62M
MSMNMosman Oil And Gas Limited	0,04p (2,56%)	263,67M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Diaceutics Plc (DXRX) Börsenkurse

Diaceutics Plc (DXRX)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Diaceutics Plc

DXRX Neueste Nachrichten

DXRX - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen